3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Trends in the long-term use of benzodiazepine anxiolytics and hypnotics: A national register study for 2006 to 2014

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Most cited references41

          • Record: found
          • Abstract: not found
          • Article: not found

          Treatment of Benzodiazepine Dependence.

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Explicit Criteria for Determining Potentially Inappropriate Medication Use by the Elderly

            Mark Beers (1997)
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              From prescription drug purchases to drug use periods – a second generation method (PRE2DUP)

              Background Databases of prescription drug purchases are now widely used in pharmacoepidemiologic studies. Several methods have been used to generate drug use periods from drug purchases to investigate various aspects; e.g., to study associations between exposure and outcome. Typically, such methods have been fairly simplistic, with fixed assumptions of drug use pattern and or dose (for example, the assumed usage of 1 tablet per day). This paper describes a novel PRE2DUP method that constructs drug use periods from purchase histories, and verified by a validation based on an expert evaluation of the drug use periods generated by the method. Methods The PRE2DUP method is a novel approach based on mathematical modelling of personal drug purchasing behaviors. The method uses a decision procedure that includes each person’s purchase history for each ATC code, processed in a chronological order. The method constructs exposure time periods and estimates the dose used during the period by considering the purchased amount in Defined Daily Doses (DDDs), which is recorded in the prescription register database. This method takes account of stockpiling of drugs, personal purchasing pattern; i.e., regularity of the purchases, and periods of hospital or nursing home care where drug use is not recorded in the prescription register. The method can be applied to a variety of drug classes with different doses and use patterns by controlling restriction parameters for each ATC class, or even each drug package. In the presented example, the PRE2DUP method was applied to a register-based MEDALZ-2005 study cohort. All drug purchases (3,793,085) recorded in the Finnish prescription register between 2002 and 2009 for persons with Alzheimer’s disease (28,093) were included. Results Results of the expert-opinion based validation indicate that PRE2DUP method creates drug use periods with a relatively high correctness. Drugs with varying patterns of use and drugs used on a short-term basis only require more precise parameters. Conclusions PRE2DUP method gives highly accurate drug use periods for most drug classes, especially those meant for long-term use.
                Bookmark

                Author and article information

                Journal
                Pharmacoepidemiology and Drug Safety
                Pharmacoepidemiol Drug Saf
                Wiley
                10538569
                June 2018
                June 2018
                May 04 2018
                : 27
                : 6
                : 674-682
                Affiliations
                [1 ]Research Unit; The Social Insurance Institution; Helsinki Finland
                [2 ]Department of Psychiatry; Turku University Hospital; Turku Finland
                [3 ]Department of Psychology and Logopedics; University of Helsinki; Helsinki Finland
                [4 ]Department of Clinical Neuroscience, Karolinska Institutet; Karolinska Universitetssjukhuset Solna; Stockholm Sweden
                [5 ]Department of Forensic Psychiatry, Niuvanniemi Hospital; University of Eastern Finland; Kuopio Finland
                [6 ]Clinical Pharmacy Group, Faculty of Pharmacy; University of Helsinki; Helsinki Finland
                Article
                10.1002/pds.4551
                29726630
                358c6451-d3e2-4970-9678-11c664870ef0
                © 2018

                http://doi.wiley.com/10.1002/tdm_license_1.1

                http://onlinelibrary.wiley.com/termsAndConditions#vor

                History

                Comments

                Comment on this article